New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
16:32 EDTNRXNephrogenex initiates pivotal oral Pyridorin Phase 3 study
NephroGenex announced it has initiated patient enrollment in the first of two pivotal Phase 3 studies in the PIONEER program for oral Pyridorin. The trial will evaluate the safety and efficacy of Pyridorin in slowing disease progression in patients with diabetic nephropathy.
News For NRX From The Last 14 Days
Check below for free stories on NRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 11, 2014
16:39 EDTNRXNephrogenex reports Q2 EPS (61c), may not compare to one estimate (24c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use